CXCL1/CXCL8 (GROα/IL-8) in human diabetic ketoacidosis plasma facilitates leukocyte recruitment to cerebrovascular endothelium in vitro

American Journal of Physiology - Endocrinology and Metabolism

Volumn 306, Issue 9, 2014, Pages

  Omatsu, Tatsushi ^a,b,c   Cepinskas, Gediminas ^a,c   Clarson, Cheril ^b,c   Patterson, Eric K ^a   Alharfi, Ibrahim M ^d   Summers, Kelly ^c   Couraud, Pierre Olivier ^e,f,g   Romero, Ignacio A ^h   Weksler, Babette ⁱ   Fraser, Douglas D ^a,b,c,j   Winston, Brent ^k   Fox Robidchaud, Alison ^k  

^a Centre for Critical Illness Research   (Canada)

^b CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d KING FAHAD MEDICAL CITY   (Saudi Arabia)

^e INSERM   (France)

^f CNRS   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h OPEN UNIVERSITY   (United Kingdom)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j Translational Research Centre   (Canada)

^k Department of Medicine Weill Cornell Medical College ^*

more..

Author keywords

Brain; Cell trafficking; Chemokines; CXC chemokine ligand; Diabetes; Growth regulated oncogene ; Human; Inflammation; Ketoacidosis; Neutrophils; Pediatric

Indexed keywords

ALPHA2 INTERFERON; CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; NEUTRALIZING ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD LEVEL; CEREBROVASCULAR ENDOTHELIUM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE ADHERENCE; MALE; MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

BRAIN; CELL TRAFFICKING; CHEMOKINES; CXC CHEMOKINE LIGAND; DIABETES; GROWTH-REGULATED ONCOGENE-Α; HUMAN; INFLAMMATION; KETOACIDOSIS; NEUTROPHILS; PEDIATRIC;

BRAIN; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CXCL1; CHEMOTAXIS, LEUKOCYTE; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; ELECTRIC IMPEDANCE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERLEUKIN-8; MALE;

EID: 84900543884     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00659.2013     Document Type: Article

References (50)

1. Brisson AR, Matsui D, Rieder MJ, Fraser DD. Translational research in pediatrics: tissue sampling and biobanking. Pediatrics 129: 153-162, 2012.
2. Cepinskas G, Katada K, Bihari A, Potter RF. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol 294: G184-G191, 2008.
3. Cepinskas G, Lush CW, Kvietys PR. Anoxia/reoxygenation-induced tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothelial cells. A nuclear factor-kappaB-mediated phenomenon. Circ Res 84: 103-112, 1999.
4. Chase HP, Garg SK, Jelley DH. Diabetic ketoacidosis in children and the role of outpatient management. Pediatr Rev 11: 297-304, 1990.
5. Chiasson JL, Aris-Jilwan N, Belanger R, Bertrand S, Beauregard H, Ekoe JM, Fournier H, Havrankova J. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ 168: 859-866, 2003.
6. Close TE, Cepinskas G, Omatsu T, Rose KL, Summers K, Patterson EK, Fraser DD. Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction. Microcirculation 20: 534-543, 2013.
7. Cotran RS, Mayadas-Norton T Endothelial adhesion molecules in health and disease. Pathol Biol (Paris) 46: 164-170, 1998.
8. Dalton RR, Hoffman WH, Passmore GG, Martin SL. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann Clin Lab Sci 33: 435-442, 2003.
9. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 89: 188-194, 2004.
10. Erbagci AB, Tarakcioglu M, Coskun Y, Sivasli E, Sibel Namiduru E. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin Biochem 34: 645-650, 2001.
11. Figueroa RE, Hoffman WH, Momin Z, Pancholy A, Passmore GG, Allison J. Study of subclinical cerebral edema in diabetic ketoacidosis by magnetic resonance imaging T2 relaxometry and apparent diffusion coefficient maps. Endocr Res 31: 345-355, 2005.
12. Foster JR, Morrison G, Fraser DD. Diabetic ketoacidosis-associated stroke in children and youth. Stroke Res Treat 2011: 219706, 2011.
13. Geiser T, Dewald B, Ehrengruber MU, Clark-Lewis I, Baggiolini M. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J Biol Chem 268: 15419-15424, 1993.
14. Gillio-Meina C, Cepinskas G, Cecchini EL, Fraser DD. Translational research in pediatrics II: blood Collection, processing, shipping, and storage. Pediatrics 131: 754-766, 2013.
15. Glaser NS, Wootton-Gorges SL, Marcin JP, Buonocore MH, Dicarlo J, Neely EK, Barnes P, Bottomly J, Kuppermann N. Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr 145: 164-171, 2004.
16. Granger DN, Senchenkova E. Inflammation and the microcirculation. In: Integrated Systems Physiology: From Molecule to Function. San Rafael, CA: Morgan & Claypool Life Sciences Publishers, 2010, vol. 2, no. 1, p. 1-87.
17. Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89: 207-215, 2011.
18. Handa O, Stephen J, Cepinskas G. Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am J Physiol Heart Circ Physiol 295: H1712-H1719, 2008.
19. Hillyer P, Mordelet E, Flynn G, Male D. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol 134: 431-441, 2003.
20. Hoffman WH, Burek CL, Waller JL, Fisher LE, Khichi M, Mellick LB. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol 108: 175-181, 2003.
21. Hoffman WH, Casanova MF, Cudrici CD, Zakranskaia E, Venugopalan R, Nag S, Oglesbee MJ, Rus H. Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis. Exp Mol Pathol 83: 65-72, 2007.
22. Hoffman WH, Helman SW, Passmore G. Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis. J Diabetes Complications 15: 144-149, 2001.
23. Hoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith MA. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res 1369: 194-202, 2011.
24. Hoffman WH, Stamatovic SM, Andjelkovic AV. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res 1254: 138-148, 2009.
25. Jerath RS, Burek CL, Hoffman WH, Passmore GG. Complement activation in diabetic ketoacidosis and its treatment. Clin Immunol 116: 11-17, 2005.
26. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149: 1-38, 2003.
27. Karavanaki K, Karanika E, Georga S, Bartzeliotou A, Tsouvalas M, Konstantopoulos I, Fotinou A, Papassotiriou I, Karayianni C. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr J 58: 1045-1053, 2011.
28. Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci 13: 2400-2407, 2008
29. L'Heureux GP, Bourgoin S, Jean N, McColl SR, Naccache PH. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood 85: 522-531, 1995.
30. Lenaz G. Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv Exp Med Biol 942: 93-136, 2012.
31. Ley K, Reutershan J. Leucocyte-endothelial interactions in health and disease. Handb Exp Pharmacol: 97-133, 2006.
32. Lin JJ, Lin KL, Wang HS, Wong AM, Hsia SH. Occult infarct with acute hemorrhagic stroke in juvenile diabetic ketoacidosis. Brain Dev 30: 91-93, 2008.
33. Lush CW, Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation 7: 83-101, 2000.
34. Mahmud FH, Ramsay DA, Levin SD, Singh RN, Kotylak T, Fraser DD. Coma with diffuse white matter hemorrhages in juvenile diabetic ketoacidosis. Pediatrics 120: e1540-e1546, 2007.
35. Oglesbee MJ, Herdman AV, Passmore GG, Hoffman WH. Diabetic ketoacidosis increases extracellular levels of the major inducible 70-kDa heat shock protein. Clin Biochem 38: 900-904, 2005.
36. Omatsu T, Naito Y, Handa O, Mizushima K, Hayashi N, Qin Y, Harusato A, Hirata I, Kishimoto E, Okada H, Uchiyama K, Ishikawa T, Takagi T, Yagi N, Kokura S, Ichikawa H, Yoshikawa T. Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury. J Gastroenterol 45: 692-702, 2010.
37. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202: 8-32, 2004.
38. Pinkey JH, Bingley PJ, Sawtell PA, Dunger DB, Gale EA. Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study Group. Diabetologia 37: 70-74, 1994.
39. Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res 43: 348-364, 2009.
40. Roe TF, Crawford TO, Huff KR, Costin G, Kaufman FR, Nelson MD Jr. Brain infarction in children with diabetic ketoacidosis. J Diabetes Complications 10: 100-108, 1996.
41. Rose KL, Pin CL, Wang R, Fraser DD. Combined insulin and bicarbonate therapy elicits cerebral edema in a juvenile mouse model of diabetic ketoacidosis. Pediatr Res 61: 301-306, 2007.
42. Rosenbloom AL, Schatz DA, Krischer JP, Skyler JS, Becker DJ, Laporte RE, Libman I, Pietropaolo M, Dosch HM, Finberg L, Muir A, Tamborlane WV, Grey M, Silverstein JH, Malone JI. Therapeutic controversy: prevention and treatment of diabetes in children. J Clin Endocrinol Metab 85: 494-522, 2000.
43. Schraufstatter IU, Chung J, Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280: L1094-L1103, 2001.
44. Schulz E, Munzel T. Intracellular pH: a fundamental modulator of vascular function. Circulation 124: 1806-1807, 2011.
45. Seo SM, McIntire LV, Smith CW. Effects of IL-8, Gro-α, and LTB4 on the adhesive kinetics of LFA-1 and Mac-1 on human neutrophils. Am J Physiol Cell Physiol 281: C1568-C1578, 2001.
46. Singh S, Wu S, Varney M, Singh AP, Singh RK. CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation. Microvasc Res 82: 318-325, 2011.
47. Takahashi K, Ohara M, Sasai T, Homma H, Nagasawa K, Takahashi T, Yamashina M, Ishii M, Fujiwara F, Kajiwara T, Taneichi H, Takebe N, Satoh J. Serum CXCL1 concentrations are elevated in type 1 diabetes mellitus, possibly reflecting activity of anti-islet autoimmune activity. Diabetes Metab Res Rev 27: 830-833, 2011.
48. Weksler B, Romero IA, Couraud PO. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10: 16, 2013.
49. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19: 1872-1874, 2005.
50. Whittall C, Kehoe O, King S, Rot A, Patterson A, Middleton J. A chemokine self-presentation mechanism involving formation of endothelial surface microstructures. J Immunol 190: 1725-1736, 2013.